EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration

Collaboration combines Exscientia’s leading AI-driven drug discovery capabilities and EQRx’s innovative development and commercialization model to substantially accelerate the delivery of novel medicines to more patients at lower prices.